Standard Biotools
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $46,718 | $44,969 | $37,205 | $45,540 |
Gross Profit | 21,905 | 23,261 | 14,908 | 24,188 |
EBITDA | -26,022 | -23,228 | -41,807 | -36,597 |
EBIT | -29,975 | -26,659 | -45,663 | -41,791 |
Net Income | -34,072 | -26,938 | -45,718 | -32,156 |
Net Change In Cash | 46,718 | 44,969 | 37,205 | 45,540 |
Free Cash Flow | -17,441 | -30,124 | -40,987 | -63,257 |
Cash | 166,728 | 210,647 | 269,811 | 287,057 |
Basic Shares | 353,245 | 371,538 | 372,331 | 294,125 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $174,432 | $106,340 | $97,948 | $130,581 |
Gross Profit | 84,262 | 50,450 | 37,051 | 77,266 |
EBITDA | -118,135 | -54,457 | -173,570 | -44,257 |
EBIT | -134,996 | -69,637 | -188,597 | -67,459 |
Net Income | -138,885 | -74,656 | -190,098 | -59,237 |
Net Change In Cash | 174,432 | 106,340 | 97,948 | 130,581 |
Cost of Revenue | 53,261 | |||
Free Cash Flow | -151,809 | -46,118 | -93,195 | -57,325 |
Cash | 166,728 | 51,704 | 81,309 | 28,451 |
Basic Shares | 353,245 | 79,160 | 78,305 | 75,786 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.04 |
2024-09-30 | -$0.07 |
2024-06-30 | -$0.12 |
2024-03-31 | -$0.27 |
